Research map: Recommendations of the Argentine Society of Rheumatology for the Treatment of Patients With Rheumatoid Arthritis: 2025 Update Part I

Back to the article

Papers in this map

  1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement · David Moher · 2009 · 38220 citations · Cited by this paper
  2. Incidence of Herpes Zoster in Patients With Rheumatoid Arthritis: Comparison With Controls and Risk According to Different Treatments · 2026 · Related
  3. Rayyan—a web and mobile app for systematic reviews · Mourad Ouzzani · 2016 · 26524 citations · Cited by this paper
  4. Ankylosing Spondylitis as a Risk Factor for Subsequent Ischemic Heart Disease · 2026 · Related
  5. GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables · Gordon Henry Guyatt · 2011 · 10869 citations · Cited by this paper
  6. Developing and Piloting a Standardized Thermography Protocol to Expedite Rheumatology Referrals for Possible Inflammatory Arthritis · 2026 · Related
  7. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update · Josef S Smolen · 2017 · 7417 citations · Cited by this paper
  8. Linear Gingival Erythema Presenting in Systemic Lupus Erythematous · 2026 · Related
  9. Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis · Steven R. Ytterberg · 2022 · 1819 citations · Cited by this paper
  10. Evolving Organizational Models in Rheumatology: Governance, Quality, and Inclusiveness in Regional Scientific Societies. The PANLAR Perspective · 2026 · Related
  11. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial · Catriona Grigor · 2004 · 1439 citations · Cited by this paper
  12. Neutrophil/Lymphocyte Ratio as a Diagnostic Tool to Distinguish Infection From Disease Reactivation in Systemic Lupus Erythematosus: An Analytical Observational Study · 2026 · Related
  13. 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis · Liana Fraenkel · 2021 · 1071 citations · Cited by this paper
  14. Nationwide Analysis of Eosinophilic Granulomatosis With Polyangiitis Hospitalizations · 2026 · Related
  15. Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies · Leroy R. Lard · 2001 · 592 citations · Cited by this paper
  16. A Convergent Mixed-methods Study of the User Perspectives for an Individualized, Computerized, Collaboratively Produced, Evidence-based Patient Self-administered Systemic Lupus Erythematosus Decision Aid · 2026 · Related
  17. Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial) · Suzanne M. M. Verstappen · 2007 · 570 citations · Cited by this paper
  18. Real-world Clinical and Diagnostic Features of Patients With Isolated Anti-SSB Antibodies Compared With Those With Combined Anti-SSA and Anti-SSB Antibodies · 2026 · Related
  19. Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate · Michael H. Schiff · 2007 · 546 citations · Cited by this paper
  20. Outcome of Children With Systemic Rheumatologic and Autoinflammatory Diseases Admitted to a Pediatric Intensive Care Unit: A Retrospective Cohort Study With Development of a Prognostic Risk-stratification Tool · 2026 · Related
  21. Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximab · Joachim Listing · 2013 · 299 citations · Cited by this paper
  22. Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial · Michael H. Schiff · 2013 · 297 citations · Cited by this paper
  23. Rheumatoid Arthritis Disease Activity Predicting Incident Clinically Apparent Rheumatoid Arthritis–Associated Interstitial Lung Disease: A Prospective Cohort Study · Jeffrey A. Sparks · 2019 · 234 citations · Cited by this paper
  24. Radiological outcome after four years of early versus delayed treatment strategy in patients with recent onset rheumatoid arthritis · Jill van Aken · 2004 · 155 citations · Cited by this paper
  25. The Prevalence of Rheumatoid Arthritis · John Barry O'Sullivan · 1972 · 139 citations · Cited by this paper
  26. 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases · Sindhu R. Johnson · 2024 · 126 citations · Cited by this paper
  27. Comparative risk of malignancies and infections in patients with rheumatoid arthritis initiating abatacept versus other biologics: a multi-database real-world study · Teresa A. Simon · 2019 · 100 citations · Cited by this paper
  28. 2022 American College of Rheumatology Guideline for Exercise, Rehabilitation, Diet, and Additional Integrative Interventions for Rheumatoid Arthritis · Bryant R. England · 2023 · 73 citations · Cited by this paper
  29. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update · Josef S Smolen · 2026 · 64 citations · Cited by this paper
  30. The impact of disease severity measures on survival in U.S. veterans with rheumatoid arthritis-associated interstitial lung disease · Rebecca T. Brooks · 2022 · 59 citations · Cited by this paper
  31. Impact of tapering targeted therapies (bDMARDs or JAKis) on the risk of serious infections and adverse events of special interest in patients with rheumatoid arthritis or spondyloarthritis: a systematic analysis of the literature and meta-analysis · DOROTHEE VINSON · 2020 · 33 citations · Cited by this paper
  32. Effects of tapering conventional synthetic disease-modifying antirheumatic drugs to drug-free remission versus stable treatment in rheumatoid arthritis (ARCTIC REWIND): 3-year results from an open-label, randomised controlled, non-inferiority trial · Kaja E Kjørholt · 2024 · 17 citations · Cited by this paper
  33. Pan American League of Associations for Rheumatology recommendations for the management of rheumatoid arthritis · Pedro Santos Moreno · 2025 · 5 citations · Cited by this paper
  34. Untitled · Cited by this paper

Source: OpenAlex (CC0)